Clinical Trial Update: A Clinical Evaluation of the ProNOVA XR Polymer Free Drug Eluting Coronary Stent System [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical evaluations of the ProNOVA XR polymer-free drug-eluting coronary stent system have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• ProNOVA XR Polymer Free Drug Eluting Coronary Stent System

Snippet

Sponsor: KCRI | Conditions: Myocardial Ischemia | Phase 2, Phase 3 | Status: COMPLETED